Alaunos Therapeutics, Inc. (TCRT)
1.50
-0.06
(-3.85%)
USD |
NASDAQ |
Sep 10, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
Alaunos Therapeutics Enterprise Value : 3.754M for Sept. 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 3.754M |
| September 08, 2026 | 3.779M |
| September 04, 2026 | 3.928M |
| September 03, 2026 | 3.978M |
| September 02, 2026 | 4.028M |
| September 01, 2026 | 4.003M |
| August 31, 2026 | 4.102M |
| August 28, 2026 | 3.866M |
| August 27, 2026 | 4.003M |
| August 26, 2026 | 4.292M |
| August 25, 2026 | 4.326M |
| August 24, 2026 | 4.152M |
| August 21, 2026 | 4.252M |
| August 20, 2026 | 4.351M |
| August 19, 2026 | 4.550M |
| August 18, 2026 | 4.550M |
| August 17, 2026 | 4.624M |
| August 14, 2026 | 4.674M |
| August 13, 2026 | 4.823M |
| August 12, 2026 | 4.848M |
| August 11, 2026 | 4.774M |
| August 10, 2026 | 4.798M |
| August 07, 2026 | 4.823M |
| August 06, 2026 | 4.823M |
| August 05, 2026 | 4.898M |
| Date | Value |
|---|---|
| August 04, 2026 | 4.600M |
| August 03, 2026 | 4.612M |
| July 31, 2026 | 4.550M |
| July 30, 2026 | 4.550M |
| July 29, 2026 | 4.600M |
| July 28, 2026 | 4.600M |
| July 27, 2026 | 4.674M |
| July 24, 2026 | 4.699M |
| July 23, 2026 | 4.649M |
| July 22, 2026 | 4.724M |
| July 21, 2026 | 5.072M |
| July 20, 2026 | 4.923M |
| July 17, 2026 | 4.972M |
| July 16, 2026 | 5.022M |
| July 15, 2026 | 5.171M |
| July 14, 2026 | 5.072M |
| July 13, 2026 | 5.057M |
| July 10, 2026 | 4.972M |
| July 09, 2026 | 5.022M |
| July 08, 2026 | 5.022M |
| July 07, 2026 | 4.948M |
| July 06, 2026 | 5.221M |
| July 02, 2026 | 5.047M |
| July 01, 2026 | 5.246M |
| June 30, 2026 | 5.495M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 557.00M |
| Amgen, Inc. | 254.84B |
| Anika Therapeutics, Inc. | 266.28M |
| BioCryst Pharmaceuticals, Inc. | 2.731B |
| Imunon, Inc. | 8.026M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.952M |
| Total Expenses (Quarterly) | 0.952M |
| EPS Diluted (Quarterly) | -0.4063 |
| Earnings Yield | -129.9% |
| Normalized Earnings Yield | -129.87 |